Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

Clinical trial NCT00850603 · COMPLETED

Trial details

NCT number: NCT00850603
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Meningococcal Infections Meningitis

Start date: 2002-10-01
Primary completion: 2003-05-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.